Your session is about to expire
← Back to Search
Endoscopy Device
PowerSpiral Enteroscopy System for Small Bowel Disease
N/A
Waitlist Available
Led By Daniel DeMarco, MD
Research Sponsored by Olympus Corporation of the Americas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative
Awards & highlights
Study Summary
The PowerSpiral Antegrade Investigational Device Exemption (IDE) Study
Eligible Conditions
- Small Bowel Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ intraoperative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Maximum depth of endoscope insertion
Rate of device related serious adverse events
Secondary outcome measures
Adverse events
Device deficiencies
Diagnostic yield
+4 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: PowerSpiral Enteroscopy SystemExperimental Treatment1 Intervention
Subjects who have a medical indication for antegrade enteroscopy
Find a Location
Who is running the clinical trial?
Olympus Corporation of the AmericasLead Sponsor
20 Previous Clinical Trials
2,115 Total Patients Enrolled
Baylor Research InstituteOTHER
200 Previous Clinical Trials
203,126 Total Patients Enrolled
University of Massachusetts, WorcesterOTHER
343 Previous Clinical Trials
986,510 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger